Lithium enhances remyelination of peripheral nerves

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 10, 2012, Pages 3973-3978

  Makoukji, Joelle ^a   Belle, Martin ^a   Meffre, Delphine ^a   Stassart, Ruth ^b   Grenier, Julien ^a   Shackleford, Ghjuvan'Ghjacumu ^a   Fledrich, Robert ^b   Fonte, Cosima ^c   Branchu, Julien ^a   Goulard, Marie ^a   De Waele, Catherine ^a   Charbonnier, Frédéric ^a   Sereda, Michael W ^b,d   Baulieu, Etienne Emile ^c   Schumacher, Michael ^c   Bernard, Sophie ^a   Massaad, Charbel ^a  

^a CNRS   (France)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c Universite Paris Sud   (France)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Neuropathy; Wnt catenin

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BETA CATENIN; LITHIUM CHLORIDE; LYMPHOID ENHANCER FACTOR 1; MYELIN; PERIPHERAL MYELIN PROTEIN 22; PLACEBO; T CELL FACTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; FACIAL NERVE INJURY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MYELIN SHEATH; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN BINDING; REMYELINIZATION; SCHWANN CELL; SCIATIC NERVE;

ANIMALS; CELL NUCLEUS; GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; MALE; MICE; MICE, INBRED C57BL; MYELIN P0 PROTEIN; MYELIN SHEATH; PERIPHERAL NERVES; PLACEBOS; PROTO-ONCOGENE PROTEINS C-AKT; SCHWANN CELLS; SCIATIC NERVE; SIGNAL TRANSDUCTION;

MUS;

EID: 84857973192     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1121367109     Document Type: Article

References (27)

1. Niemann A, Berger P, Suter U (2006) Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Neuromolecular Med 8:217-242.
2. Garbay B, Heape AM, Sargueil F, Cassagne C (2000) Myelin synthesis in the peripheral nervous system. Prog Neurobiol 61:267-304. (Pubitemid 30155722)
3. Slutsky SG, Kamaraju AK, Levy AM, Chebath J, Revel M (2003) Activation of myelin genes during transdifferentiation from melanoma to glial cell phenotype. J Biol Chem 278:8960-8968. (Pubitemid 36800373)
4. Tawk M, et al. (2011) Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J Neurosci 31:3729-3742.
5. Phiel CJ, Klein PS (2001) Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 41:789-813. (Pubitemid 32385907)
6. Zhong J, Yang X, Yao W, Lee W (2006) Lithium protects ethanol-induced neuronal apoptosis. Biochem Biophys Res Commun 350:905-910. (Pubitemid 44596222)
7. Chuang DM (2005) The antiapoptotic actions of mood stabilizers: Molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci 1053:195-204.
8. Wei H, et al. (2001) Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 106:603-612. (Pubitemid 32925248)
9. Noble W, et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102:6990-6995. (Pubitemid 40675429)
10. Youdim MB, Arraf Z (2004) Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: Involvements of Bcl-2 and Bax. Neuropharmacology 46:1130-1140. (Pubitemid 38529937)
11. De Sarno P, et al. (2008) Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol 181:338-345.
12. Wrabetz L, et al. (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1034.
13. Makoukji J, et al. (2011) Interplay between LXR and Wnt/beta-catenin signalling in the negative regulation of peripheral myelin genes by oxysterols. J Neurosci 26: 9620-9629.
14. Hedgepeth CM, et al. (1997) Activation of the Wnt signaling pathway: A molecular mechanism for lithium action. Dev Biol 185:82-91. (Pubitemid 27244219)
15. Bhat RV, Budd Haeberlein SL, Avila J (2004) Glycogen synthase kinase 3: A drug target for CNS therapies. J Neurochem 89:1313-1317. (Pubitemid 38802652)
16. Takahashi-Yanaga F, Sasaguri T (2009) Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: Inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci 109:179-183.
17. Gould TD, Chen G, Manji HK (2004) In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29:32-38. (Pubitemid 38068011)
18. Pies R (2002) Combining lithium and anticonvulsants in bipolar disorder: A review. Ann Clin Psychiatry 14:223-232.
19. Zhong J, Lee WH (2007) Lithium: A novel treatment for Alzheimer's disease? Expert Opin Drug Saf 6:375-383. (Pubitemid 351308166)
20. Chuang DM (2004) Neuroprotective and neurotrophic actions of the mood stabilizer lithium: Can it be used to treat neurodegenerative diseases? Crit Rev Neurobiol 16: 83-90.
21. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455-8459. (Pubitemid 26269579)
22. Mori S, et al. (1996) Inhibitory effect of lithium on cAMP dependent phosphorylation system. Life Sci 59:PL99-PL104. (Pubitemid 26274461)
23. Einat H, Yuan P, Szabo ST, Dogra S, Manji HK (2007) Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: Implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 55:123-131. (Pubitemid 47525230)
24. Su H, Chu TH, Wu W (2007) Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol 206:296-307. (Pubitemid 47094774)
25. Adams JM, Cory S (1998) The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326. (Pubitemid 28406819)
26. Sadoul R (1998) Bcl-2 family members in the development and degenerative pathologies of the nervous system. Cell Death Differ 5:805-815.
27. Basselin M, Villacreses NE, Lee HJ, Bell JM, Rapoport SI (2007) Chronic lithium administration attenuates up-regulated brain arachidonic acid metabolism in a rat model of neuroinflammation. J Neurochem 102:761-772. (Pubitemid 47057299)